公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | High burden of antimicrobial drug resistance in Asia | Lai C.-C.; Lee K.; Xiao Y.; Ahmad N.; Veeraraghavan B.; Thamlikitkul V.; Tambyah P.A.; Nelwan R.H.H.; Shibl A.M.; Wu J.-J.; Seto W.-H.; PO-REN HSUEH | Journal of Global Antimicrobial Resistance | 58 | 47 | |
2020 | The practice of gastrointestinal motility laboratory during COVID-19 pandemic: Position statements of the Asian neurogastroenterology and motility association (ANMA-GML-COVID-19 position statements) | Siah K.T.H.; Rahman M.M.; Ong A.M.L.; Soh A.Y.S.; Lee Y.Y.; Xiao Y.; Sachdeva S.; Jung K.W.; Wang Y.-P.; Oshima T.; Patcharatrakul T.; PING-HUEI TSENG ; Goyal O.; Pang J.; Lai C.K.C.; Park J.H.; Mahadeva S.; Cho Y.K.; Wu J.C.Y.; Ghoshal U.C.; Miwa H. | Journal of Neurogastroenterology and Motility | 8 | 7 | |
2019 | Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial | Yuan J.; Mo B.; Ma Z.; Lv Y.; Cheng S.-L.; Yang Y.; Tong Z.; Wu R.; Sun S.; Cao Z.; Wu J.; Zhu D.; Chang L.; Zhang Y.; Zhao L.; Wang X.; Wang X.; Wang D.; Li X.; Peng Y.; Liang Y.; Liu H.; Xiao Z.; Lv X.; Wu S.; Dai Y.; Huang Y.; Hu Z.; Qiu C.; Li X.; Zhang S.; Li W.; Liu S.; Shi Y.; Xiong C.; Kuang J.; Xiu Q.; Cui S.; Li J.; Lin Q.; Huang W.; Wan Y.; Qimanguli, Shen C.; Xiao Y.; Wu X.; Chuang Y.C.; Perng W.C.; Tsao S.-M.; Hsu J.-Y.; Wang C.-C.; Wang J.-H.; Yeh P.-F.; Lin H.-H.; PING-HUNG KUO ; Lin M.-S.; Su W.-J.; Investigator Group of the Phase 3 Study on Oral Nemonoxacin | Journal of Microbiology, Immunology and Infection | 28 | 26 | |
2006 | Searching for HLA-DRB1*1206 in volunteer marrow donors in four US population groups | Lazaro A.-M. ; Steiner N.-K.; Cao K.; Slack R.; DING-SHINN CHEN ; Xiao Y.; Beduhn E.; Ng J.; Hartzman R.-J.; Hurley C.-K. | Tissue Antigens | 4 | 3 |